These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10407251)

  • 1. Visit-driven endpoints in randomized HIV/AIDS clinical trials: impact of missing data on treatment difference measured on summary statistics.
    Le Corfec E; Chevret S; Costagliola D
    Stat Med; 1999 Jul; 18(14):1803-17; discussion 1819. PubMed ID: 10407251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: a meta-analysis. HIV Surrogate Marker Collaborative Group.
    AIDS Res Hum Retroviruses; 2000 Aug; 16(12):1123-33. PubMed ID: 10954887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral load as a primary outcome in human immunodeficiency virus trials: a review of statistical analysis methods.
    Journot V; Chêne G; Joly P; Savès M; Jacqmin-Gadda H; Molina JM; Salamon R;
    Control Clin Trials; 2001 Dec; 22(6):639-58. PubMed ID: 11738121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of missing data due to drop-outs on estimators for rates of change in longitudinal studies: a simulation study.
    Touloumi G; Babiker AG; Pocock SJ; Darbyshire JH
    Stat Med; 2001 Dec; 20(24):3715-28. PubMed ID: 11782028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case for preART-adjusted endpoints in HIV therapeutic vaccine trials.
    Huang Y; Zhang L; Jolliffe D; Hovden AO; Ökvist M; Pantaleo G; Sommerfelt MA
    Vaccine; 2016 Mar; 34(10):1282-8. PubMed ID: 26826543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.
    Phillips AN; Eron J; Bartlett J; Kuritzkes DR; Johnson VA; Gilbert C; Johnson J; Keller A; Hill AM
    AIDS; 1997 Feb; 11(2):169-75. PubMed ID: 9030363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.
    Baxter JD; Mayers DL; Wentworth DN; Neaton JD; Hoover ML; Winters MA; Mannheimer SB; Thompson MA; Abrams DI; Brizz BJ; Ioannidis JP; Merigan TC
    AIDS; 2000 Jun; 14(9):F83-93. PubMed ID: 10894268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical approach to adjusting for attrition bias in HIV clinical trials with serial marker responses.
    Cozzi Lepri A; Smith GD; Mocroft A; Sabin CA; Morris RW; Phillips AN
    AIDS; 1998 Jul; 12(10):1155-61. PubMed ID: 9677164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
    Hughes MD; Johnson VA; Hirsch MS; Bremer JW; Elbeik T; Erice A; Kuritzkes DR; Scott WA; Spector SA; Basgoz N; Fischl MA; D'Aquila RT
    Ann Intern Med; 1997 Jun; 126(12):929-38. PubMed ID: 9182469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
    Kim S; Hughes MD; Hammer SM; Jackson JB; DeGruttola V; Katzenstein DA
    AIDS Res Hum Retroviruses; 2000 May; 16(7):645-53. PubMed ID: 10791875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of lamivudine treatment on HIV-1 disease progression are highly correlated with plasma HIV-1 RNA and CD4 cell count.
    Montaner JS; DeMasi R; Hill AM
    AIDS; 1998 Mar; 12(5):F23-8. PubMed ID: 9543436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Martin D; Esinhart J; Hill A; Benoit S; Rubin M; Simberkoff MS; Hamilton JD
    N Engl J Med; 1996 Feb; 334(7):426-31. PubMed ID: 8552144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust analysis of biomarker data with informative missingness using a two-stage hypothesis test in an HIV treatment interruption trial: AIEDRP AIN503/ACTG A5217.
    Messer K; Vaida F; Hogan C
    Contemp Clin Trials; 2006 Dec; 27(6):506-17. PubMed ID: 16962381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.
    O'Brien WA; Hartigan PM; Daar ES; Simberkoff MS; Hamilton JD
    Ann Intern Med; 1997 Jun; 126(12):939-45. PubMed ID: 9182470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 x 10(6) cells/l.
    Chapman LE; Green TA; Ahmed F; Parekh BS; Rimland D; Kaplan JE; Thompson MA; Folks TM
    AIDS; 2000 Jun; 14(9):1135-46. PubMed ID: 10894277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial imputation approach to analysis of repeated measurements with dependent drop-outs.
    Wei L; Shih WJ
    Stat Med; 2001 Apr; 20(8):1197-214. PubMed ID: 11304736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Weng S; Carrington M; Mellors J; Rinaldo CR; Mann D; Apple R; Phair JP; Detels R; O'Brien S; Enger C; Johnson P; Kaslow RA
    AIDS; 1998 Nov; 12(16):2107-13. PubMed ID: 9833851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation and comparison of rates of change in longitudinal studies with informative drop-outs.
    Touloumi G; Pocock SJ; Babiker AG; Darbyshire JH
    Stat Med; 1999 May; 18(10):1215-33. PubMed ID: 10363341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.